ELEKTA HAS REPURCHASED OWN SHARES FOR SEK 100 M

ELEKTA HAS REPURCHASED OWN SHARES FOR SEK 100 M

PRESS RELEASE			
Stockholm, Sweden, July 13, 2007

During the period July 4 through July 12, 2007, Elekta has repurchased 871,600 B
shares at an average price of SEK 114.73 totaling SEK 99,997,612. 

Accordingly, Elekta's current holding of own shares (treasury stock) amounts to
1,630,871 B shares, which Elekta's Board intends to propose to the AGM to be
cancelled. 

These repurchases were carried out in line with the Board's decision on July 2,
2007, to mandate the executive management to initiate repurchase of shares in an
amount of SEK 100 M. 

The total number of shares in Elekta (prior to cancellation of the shares now
repurchased) amounts to 93,794,776.

******

For further information, please contact:

Okee Williams 
Corporate Communications, Elekta AB 
Tel: +46 70 600 53 64 (mobile), e-mail: okee.williams@elekta.com 

About Elekta

Elekta is an international medical-technology Group, providing meaningful
clinical solutions, comprehensive information systems and services for improved
cancer care and management of brain disorders. All of Elekta's solutions employ
non-invasive or minimally invasive techniques and are therefore clinically
effective, gentle on the patient and cost-effective. 

Clinical solutions include among others Leksell Gamma Knife® for non-invasive
treatment of brain disorders and Elekta Synergy® for image guided radiation
therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April
2005, the Elekta Group is the world's largest supplier of oncology software. 

Elekta's systems and solutions are used at over 4,000 hospitals around the world
to treat cancer and manage clinical operations as well as to diagnose and treat
brain disorders, including tumors, vascular malformations and functional
disorders. 

With approx. 2,000 employees, Elekta's corporate headquarter is located in
Stockholm, Sweden and the company is listed on the Nordic Exchange under the
ticker EKTAb. For more information about Elekta, please visit www.elekta.com.